Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 2001;97:510-514
© 2001 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BENSON, M. D.
Right arrow Articles by TERAO, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BENSON, M. D.
Right arrow Articles by TERAO, T.

ORIGINAL RESEARCH

Immunologic Studies in Presumed Amniotic Fluid Embolism

MICHAEL D. BENSON, MD, HIROSHI KOBAYASHI, MD, PhD, RICHARD K. SILVER, MD, HIDEKAZU OI, MD, PhD, PAUL A. GREENBERGER, MD and TOSHIHIKO TERAO, MD, PhD

From the Department of Obstetrics and Gynecology, Northwestern University Medical School, Chicago, Illinois; Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan; and Division of Allergy and Immunology, Department of Medicine, Northwestern University Medical School, Chicago, Illinois.

Address reprint requests to: Michael D. Benson, MD Department of Obstetrics and Gynecology Northwestern University Medical School 101 Bentley Court Deerfield, IL 60015 E-mail: michaelbenson{at}home.com.

Objective: To evaluate the potential role of immunologic mechanisms that involve mast cell degranulation (anaphylaxis) or complement activation in the mechanism of amniotic fluid embolism.

Methods: This study was a case series of nine women with presumed amniotic fluid embolism and a control group of 22 women who had normal labor. Women were from community and tertiary referral hospitals in Japan and the United States. Main outcome measures were maternal peripartum complement levels (C3 and C4), serum levels of tryptase, urinary histamine concentrations, and serum levels of a fetal antigen (sialyl Tn).

Results: Serum tryptase and urinary histamine measurements were negative in women with amniotic fluid embolism; seven of nine had elevated levels of fetal antigen. All eight who had serum available for testing had abnormally low levels of complement. Mean C3 level of 44.0 mg/dL and C4 level of 10.7 mg/dL were significantly lower than corresponding postpartum control values of 117.3 mg/dL and 29.4 mg/dL (P = .018 for C3, P = .012 for C4). Postpartum C3 and C4 levels decreased by 8% and 5%, respectively, compared with intrapartum values (P = .003 for C3, P = .021 for C4) but were still within normal range.

Conclusion: Serologic findings suggest a role for complement activation in the mechanism of amniotic fluid embolism. Laboratory data from this series did not implicate mast cell degranulation (anaphylaxis) in the pathophysiology of the disease.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Obstetricians and Gynecologists.